Market Tracker

09/02 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
120.10 +2.80 / +2.39%
Data as of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
119.91 -0.1935 / -0.16%
 
Volume: 12.4K

Today’s Trading

Previous close117.30
Today’s open117.28
Day’s range116.67 - 120.43
Volume1,916,662
Average volume (3 months)2,852,234
Market cap$39.1B
Dividend yield--
Data as of 4:01pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+28.09%
Earnings growth (next 5 years)+57.40%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book7.63

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.15-0.09%
SHPGShire PLC-0.75-0.31%
AGNAllergan Inc+2.77+1.69%
VRTXVertex Pharmaceutica...-0.61-0.65%
Data as of 4:14pm ET, 09/02/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$1.96
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts